41 related articles for article (PubMed ID: 33486102)
1. A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.
Garant A; Spears G; Routman D; Whitaker T; Liao Z; Harmsen W; Liu A; Haddock M; Hallemeier C; Lin S; Merrell K
Pract Radiat Oncol; 2021; 11(4):e415-e425. PubMed ID: 33486102
[TBL] [Abstract][Full Text] [Related]
2. Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617.
Ladbury C; Li R; Danesharasteh A; Ertem Z; Tam A; Liu J; Hao C; Li R; McGee H; Sampath S; Williams T; Glaser S; Khasawneh M; Liao Z; Lee P; Ryckman J; Shaikh P; Amini A
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1287-1296. PubMed ID: 37406826
[TBL] [Abstract][Full Text] [Related]
3. Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose.
Niska JR; Hu J; Li J; Herman MG; Thorpe CS; Schild SE; Fatyga M
J Cancer Ther; 2021 Sep; 12(9):505-529. PubMed ID: 34804634
[TBL] [Abstract][Full Text] [Related]
4. Effect of accurate heart delineation on cardiac dose during the CONVERT trial.
Groom N; Wilson E; Faivre-Finn C
Br J Radiol; 2017 May; 90(1073):20170036. PubMed ID: 28362511
[TBL] [Abstract][Full Text] [Related]
5. Demystifying the Results of RTOG 0617: Identification of Dose Sensitive Cardiac Subregions Associated With Overall Survival.
McWilliam A; Abravan A; Banfill K; Faivre-Finn C; van Herk M
J Thorac Oncol; 2023 May; 18(5):599-607. PubMed ID: 36738929
[TBL] [Abstract][Full Text] [Related]
6. Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity.
Zhang A; Deek MP; Kim S; Sayan M; Grann A; Wagman RT; Malhotra U; Hathout L; Biswal N; Zhang Y; Langenfeld J; Kennedy T; August DA; Jabbour SK
J Gastrointest Oncol; 2019 Jun; 10(3):513-522. PubMed ID: 31183202
[TBL] [Abstract][Full Text] [Related]
7. Advances in Radiotherapy Management of Esophageal Cancer.
Verma V; Moreno AC; Lin SH
J Clin Med; 2016 Oct; 5(10):. PubMed ID: 27775643
[TBL] [Abstract][Full Text] [Related]
8. Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study.
Al-Kaabi A; van der Post RS; van der Werf LR; Wijnhoven BPL; Rosman C; Hulshof MCCM; van Laarhoven HWM; Verhoeven RHA; Siersema PD
Acta Oncol; 2021 Apr; 60(4):497-504. PubMed ID: 33491513
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis.
Jeong Y; Lee KJ; Lee SJ; Shin YM; Kim MJ; Lim YS; Lee HC; Jung J; Park JH; Kim JH; Kim SY; Yoon SM
J Gastroenterol Hepatol; 2021 Jul; 36(7):1962-1970. PubMed ID: 33594690
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
11. KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma.
Shah MA; Bennouna J; Doi T; Shen L; Kato K; Adenis A; Mamon HJ; Moehler M; Fu X; Cho BC; Bordia S; Bhagia P; Shih CS; Desai A; Enzinger P
Future Oncol; 2021 Apr; 17(10):1143-1153. PubMed ID: 33533655
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.
Tlemsani C; Takahashi N; Pongor L; Rajapakse VN; Tyagi M; Wen X; Fasaye GA; Schmidt KT; Desai P; Kim C; Rajan A; Swift S; Sciuto L; Vilimas R; Webb S; Nichols S; Figg WD; Pommier Y; Calzone K; Steinberg SM; Wei JS; Guha U; Turner CE; Khan J; Thomas A
Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33504652
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
van den Ende T; de Clercq NC; van Berge Henegouwen MI; Gisbertz SS; Geijsen ED; Verhoeven RHA; Meijer SL; Schokker S; Dings MPG; Bergman JJGHM; Haj Mohammad N; Ruurda JP; van Hillegersberg R; Mook S; Nieuwdorp M; de Gruijl TD; Soeratram TTD; Ylstra B; van Grieken NCT; Bijlsma MF; Hulshof MCCM; van Laarhoven HWM
Clin Cancer Res; 2021 Jun; 27(12):3351-3359. PubMed ID: 33504550
[TBL] [Abstract][Full Text] [Related]
14. Comparison of esketamine versus dexmedetomidine for attenuation of cardiovascular stress response to double-lumen tracheal tube intubation: a randomized controlled trial.
Liu C; Zhang T; Cao L; Lin W
Front Cardiovasc Med; 2023; 10():1289841. PubMed ID: 38188254
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict cardiac death after radiotherapy for esophageal cancer.
Lv X; Wu X; Liu K; Zhao X; Pan C; Zhao J; Chang J; Guo H; Gao X; Zhi X; Ren C; Chen Q; Jiang H; Wang C; Li YD
Cancer Innov; 2023 Oct; 2(5):391-404. PubMed ID: 38090380
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer.
Kowalchuk RO; Spears GM; Morris LK; Owen D; Yoon HH; Jethwa K; Chuong MD; Ferris MJ; Haddock MG; Hallemeier CL; Wigle D; Lin SH; Merrell KW
Front Oncol; 2023; 13():1081024. PubMed ID: 36845682
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure.
Ritter A; Quartermaine C; Pierre-Charles J; Balasubramanian S; Raeisi-Giglou P; Addison D; Miller E
Curr Heart Fail Rep; 2023 Feb; 20(1):44-55. PubMed ID: 36692820
[TBL] [Abstract][Full Text] [Related]
18. CArdiac and REspiratory adaptive Computed Tomography (CARE-CT): a proof-of-concept digital phantom study.
Morton N; Keall P; O'Brien R; Reynolds T
Phys Eng Sci Med; 2022 Dec; 45(4):1257-1271. PubMed ID: 36434201
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Simultaneous Integrated Boost Intensity-Modulation Radiation Therapy Combined with Systematic and Standardized Management for Esophageal Cancer.
Deng W; Zhang X; Su J; Song C; Xu J; Zhao X; Shen W
Front Surg; 2022; 9():905678. PubMed ID: 35677748
[TBL] [Abstract][Full Text] [Related]
20. All for one, though not one for all: team players in normal tissue radiobiology.
Boerma M; Davis CM; Jackson IL; Schaue D; Williams JP
Int J Radiat Biol; 2022; 98(3):346-366. PubMed ID: 34129427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
